Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine vs Remifentanil in Mastectomy
NCT02291094Phase 4Completed
- Sponsor
- Hospital de Base de São José do Rio Preto
- Start
- Aug 2013
- Primary completion
- Aug 2014
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of Lidocaine Hydrochloride Injection, without epinephrine in postoperative pain (2 arms), sponsored by Hospital de Base de São José do Rio Preto. Primary endpoint: Evaluation of post-operative pain at 24 hours. Started Aug 2013; status: completed.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02291094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02291094.